Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Amgen
Novartis
Information provided by (Responsible Party):
Shadia Jalal, Indiana University School of Medicine
ClinicalTrials.gov Identifier:
NCT01122199
First received: May 7, 2010
Last updated: April 15, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)